Chr. Hansen Holding A/S
Chr. Hansen is a global bioscience company.
Launch date
Employees
Market cap
AUD16.8b
Enterprise valuation
AUD18.4b (Public information from Jan 2024)
Share price
DKK549.6 CHR.CO
Hørsholm Capital Region of Denmark (HQ)
Financials
Estimates*
| EUR | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenues | 970m | 1.1b | 1.2b | 1.3b | 1.4b | 1.5b |
| % growth | - | 11 % | 13 % | 9 % | 7 % | 6 % |
| EBITDA | 406m | 389m | 422m | - | - | - |
| % EBITDA margin | 42 % | 36 % | 35 % | - | - | - |
| Profit | 245m | 845m | 225m | - | - | - |
| % profit margin | 25 % | 78 % | 18 % | - | - | - |
| R&D budget | 76.2m | 90.1m | 96.8m | - | - | - |
| R&D % of revenue | 8 % | 8 % | 8 % | - | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | N/A | IPO | |
€560m | Secondary | ||
* | N/A | Acquisition | |
| Total Funding | - | ||
Related Content
Recent News about Chr. Hansen Holding A/S
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Chr. Hansen Holding A/S
Edit
ACQUISITION by Chr. Hansen Holding A/S Jul 2020